Cover image of the article: A new scoring system for prediction of fibrosis in chronic hepatitis C

Image Credit:Hepat Mon

A new scoring system for prediction of fibrosis in chronic hepatitis C

Authors

Simona Bota1,*, Roxana Sirli2, Ioan Sporea2, Mircea Focsa2, Alina Popescu2, Mirela Danila2, Mihnea Strain2, Madalina Sendroiu2, Alexandra Deleanu2, Isabel Dan2
1Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, bota_simona1982@yahoo.com, Romania
2Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Romania
*Corresponding Author: Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, bota_simona1982@yahoo.com, Romania. Tel: +40-721656147. Fax: +40-256488003. Email: bota_simona1982@yahoo.com

Hepatitis Monthly:Vol. 11, issue 7; 548-555
Published online:Jul 31, 2011
Article type:Research Article
Received:Feb 20, 2011
Accepted:Jun 24, 2011
How to Cite:Bota S, Sirli R, Sporea I, Focsa M, Popescu A, et al. A new scoring system for prediction of fibrosis in chronic hepatitis C. Hepat Mon. 2011;11(7):. doi:

Abstract

Background: Liver biopsy (LB) is still considered to be the gold standard for assessment of liver fibrosis.
Objectives: To evaluate the effectiveness of various non-invasive methods for predicting liver fibrosis, including transient elastography (TE), APRI score, Lok score, Forns score, FIB-4 score, Fibrosis Index, King score, and Bonacini score, in comparison with the effectiveness of LB and to create a new scoring system for fibrosis prediction.
Patients and Methods: This study included 212 patients with chronic HCV hepatitis. LB, TE, and various biological tests were performed during a single hospital visit. Using established formulae, data from these tests were used to create scores for assessment of liver fibrosis.
Results: The results of all the tests showed significant correlation with histological fibrosis. TE results (r = 0.62), King score (r = 0.57), and APRI score (r = 0.56) showed the closest correlation with severity of fibrosis. The following formula was derived from our data by multiple regression: Predicted liver fibrosis score (PLF score) = 0.956 + 0.084 × TE - 0.004 × King score + 0.124 × Forns score + 0.202 × APRI score. A direct correlation (r = 0.68) was found between the PLF score and liver fibrosis. The cut-off values of the PLF score for various stages of fibrosis were: F ≥ 1, 1.77 (Area under ROC curve (AUROC) = 0.76); F ≥ 2, 2.18 (AUROC = 0.78); F ≥ 3, 2.47 (AUROC = 0.86); and F = 4, 2.98 (AUROC = 0.97).
Conclusions: We found that our newly developed PLF score, which is derived from the scores of multiple tests, is more strongly correlated with fibrosis than each component score used individually. The PLF score is more effective than TE for predicting severe fibrosis, but they have similar effectiveness in predicting liver cirrhosis. 


  • Implication for health policy/practice/research/medical education:
    Evaluation of fibrosis is important for the assessment of chronic HCV hepatitis. In the last years the noninvasive methods are increasingly used and this is an improvement in the field of hepatology. The original article tries to open a new window for gastroenterologists, hepatologists, and other clinicians in the field.
  • Please cite this paper as:
    Bota S, Sirli R, Sporea I, Focsa M, Popescu A, Danila M, et al. A new scoring system for prediction of fibrosis in chronic hepatitis C. Hepat Mon. 2011;11(7):548-5.

© 2011 Kowsar M.P.Co. All rights reserved.


Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

10
Feb
2018
SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B

SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B

Fatma Demet Arslan,
Inanc Karakoyun,
Bengu Tatar,
Emel Ebru Pala,
Mustafa Yıldırım,
Celal Ulasoglu
,et al.

Arslan FD, Karakoyun I, Tatar B, Pala EE, Yıldırım M, et al. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepat Mon. 2018;18(2):e63310. doi: https://doi.org/10.5812/hepatmon.63310

30
Jun
2010
A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

Ali Kabir,
Seyed Tabatabaei,
Siamak Khaleghi,
Shahram Agah,
Amir Hossein Kashani,
Mehrdad Moghimi
,et al.

Kabir A, Tabatabaei S, Khaleghi S, Agah S, Kashani AH, et al. A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection. Hepat Mon. 2010;10(3):. doi:

30
Jun
2010
A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

Shiying Li,
Peng Hu,
Qin-Qin Zhang,
Ying-Hong Liu,
Huai-Dong Hu,
Da-Zhi Zhang
,et al.

Li S, Hu P, Zhang Q, Liu Y, Hu H, et al. A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection. Hepat Mon. 2011;11(3):. doi:

30
Jun
2010
A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

Ioan Sporea,
Simona Bota,
Alina Popescu,
Marioara Cornianu,
Roxana Sirli

Sporea I, Bota S, Popescu A, Cornianu M, Sirli R. A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection. Hepat Mon. 2010;10(2):. doi:

30
Jun
2010
A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection

Shahed Rezamand,
Zahra Goodarzi,
Seyyed Mohammad Miri

Rezamand S, Goodarzi Z, Miri SM. A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection. Hepat Mon. 2008;8(3):. doi:

More by these authors

Simona BotaPubMedScholar
Roxana SirliPubMedScholar
Ioan SporeaPubMedScholar
Mircea FocsaPubMedScholar
Alina PopescuPubMedScholar
Mirela DanilaPubMedScholar
Mihnea StrainPubMedScholar
Madalina SendroiuPubMedScholar
Alexandra DeleanuPubMedScholar
Isabel DanPubMedScholar
Share
Cited by
Metrics